Fernando Roncolato

565 total citations
17 papers, 183 citations indexed

About

Fernando Roncolato is a scholar working on Pathology and Forensic Medicine, Oncology and Hematology. According to data from OpenAlex, Fernando Roncolato has authored 17 papers receiving a total of 183 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pathology and Forensic Medicine, 8 papers in Oncology and 5 papers in Hematology. Recurrent topics in Fernando Roncolato's work include Lymphoma Diagnosis and Treatment (7 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Acute Myeloid Leukemia Research (3 papers). Fernando Roncolato is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Acute Myeloid Leukemia Research (3 papers). Fernando Roncolato collaborates with scholars based in Australia, United States and Italy. Fernando Roncolato's co-authors include Beng H. Chong, Xavier C. Badoux, Shir‐Jing Ho, Philip Choi, Frank Firkin, Wai Khoon Ho, Jiuhong Zha, Amer M. Zeidan, Ashish Bajel and David Hoffman and has published in prestigious journals such as Blood, British Journal of Haematology and Occupational and Environmental Medicine.

In The Last Decade

Fernando Roncolato

15 papers receiving 180 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fernando Roncolato Australia 8 109 66 57 48 39 17 183
Kalman Filanovsky Israel 6 125 1.1× 41 0.6× 38 0.7× 44 0.9× 36 0.9× 21 192
Fatima Zahra Jelloul United States 8 92 0.8× 29 0.4× 61 1.1× 34 0.7× 63 1.6× 32 172
Zoé Van de Wyngaert France 8 138 1.3× 25 0.4× 81 1.4× 25 0.5× 68 1.7× 22 191
Ryan J. Stubbins Canada 9 102 0.9× 37 0.6× 94 1.6× 81 1.7× 80 2.1× 26 286
Michel Maigre France 6 80 0.7× 38 0.6× 55 1.0× 23 0.5× 92 2.4× 12 200
Pedro Sánchez‐Godoy Spain 7 48 0.4× 100 1.5× 99 1.7× 46 1.0× 65 1.7× 18 220
Carmen Sanzo Spain 5 166 1.5× 55 0.8× 48 0.8× 84 1.8× 24 0.6× 5 211
Kaiyang Ding China 9 107 1.0× 36 0.5× 100 1.8× 30 0.6× 113 2.9× 51 241
H. Kreipe Germany 5 124 1.1× 18 0.3× 42 0.7× 48 1.0× 28 0.7× 13 172
Shlomzion Aumann Israel 7 53 0.5× 24 0.4× 97 1.7× 33 0.7× 51 1.3× 25 160

Countries citing papers authored by Fernando Roncolato

Since Specialization
Citations

This map shows the geographic impact of Fernando Roncolato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fernando Roncolato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fernando Roncolato more than expected).

Fields of papers citing papers by Fernando Roncolato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fernando Roncolato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fernando Roncolato. The network helps show where Fernando Roncolato may publish in the future.

Co-authorship network of co-authors of Fernando Roncolato

This figure shows the co-authorship network connecting the top 25 collaborators of Fernando Roncolato. A scholar is included among the top collaborators of Fernando Roncolato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fernando Roncolato. Fernando Roncolato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Odutola, Michael K., Marina T. van Leeuwen, Fiona Bruinsma, et al.. (2023). Occupational exposure to extremely low-frequency magnetic fields and follicular lymphoma risk: a family case–control study. Occupational and Environmental Medicine. 80(10). 599–602.
2.
Odutola, Michael K., Marina T. van Leeuwen, Julie K. Bassett, et al.. (2023). Dietary intake of animal-based products and likelihood of follicular lymphoma and survival: A population-based family case-control study. Frontiers in Nutrition. 9. 1048301–1048301.
3.
Odutola, Michael K., Marina T. van Leeuwen, Fiona Bruinsma, et al.. (2023). A Population-Based Family Case–Control Study of Sun Exposure and Follicular Lymphoma Risk. Cancer Epidemiology Biomarkers & Prevention. 33(1). 106–116. 1 indexed citations
4.
Odutola, Michael K., Marina T. van Leeuwen, Jennifer Turner, et al.. (2022). Associations between early-life growth pattern and body size and follicular lymphoma risk and survival: a family-based case-control study. Cancer Epidemiology. 80. 102241–102241. 2 indexed citations
5.
Zeidan, Amer M., Uma Borate, Daniel A. Pollyea, et al.. (2022). A phase 1b study of venetoclax and azacitidine combination in patients with relapsed or refractory myelodysplastic syndromes. American Journal of Hematology. 98(2). 272–281. 41 indexed citations
6.
Odutola, Michael K., Marina T. van Leeuwen, Jennifer Turner, et al.. (2022). Associations between Smoking and Alcohol and Follicular Lymphoma Incidence and Survival: A Family-Based Case-Control Study in Australia. Cancers. 14(11). 2710–2710. 8 indexed citations
7.
Zeidan, Amer M., Uma Borate, Daniel A. Pollyea, et al.. (2021). Venetoclax and Azacitidine in the Treatment of Patients with Relapsed/Refractory Myelodysplastic Syndrome. Blood. 138(Supplement 1). 537–537. 13 indexed citations
8.
Hawkes, Eliza A., Tycel Phillips, Lihua E. Budde, et al.. (2021). Avelumab in Combination Regimens for Relapsed/Refractory DLBCL: Results from the Phase Ib JAVELIN DLBCL Study. Targeted Oncology. 16(6). 761–771. 10 indexed citations
9.
Roncolato, Fernando, et al.. (2021). Lysosomal acid lipase deficiency diagnosed in a patient presenting with acute myeloid leukaemia. British Journal of Haematology. 194(2). 228–228. 1 indexed citations
10.
Roncolato, Fernando, et al.. (2020). Recurrent ventricular fibrillation with different tyrosine kinase inhibitors for chronic myeloid leukemia. HeartRhythm Case Reports. 6(10). 770–773. 2 indexed citations
11.
12.
Choi, Philip, et al.. (2015). A novel triple therapy for ITP using high-dose dexamethasone, low-dose rituximab, and cyclosporine (TT4). Blood. 126(4). 500–503. 53 indexed citations
13.
Firkin, Frank, Fernando Roncolato, & Wai Khoon Ho. (2015). Dose‐adjusted arsenic trioxide for acute promyelocytic leukaemia in chronic renal failure. European Journal Of Haematology. 95(4). 331–335. 11 indexed citations
14.
Roncolato, Fernando, et al.. (2011). Targeted molecular therapy in peripheral T-cell lymphomas. Expert Review of Hematology. 4(5). 551–562. 6 indexed citations
15.
Mannu, Claudia, Anna Gazzola, Francesco Bacci, et al.. (2011). Use of IGK gene rearrangement analysis for clonality assessment of lymphoid malignancies: a single center experience.. PubMed. 1(2). 167–74. 11 indexed citations
16.
Choi, Philip, et al.. (2011). The Mortality of Vancomycin-Resistant Enterococci Bloodstream Infections (VRE BSI). Blood. 118(21). 4928–4928. 2 indexed citations
17.
Piccaluga, Pier Paolo, Anna Gazzola, Claudia Mannu, et al.. (2010). Pathobiology of Anaplastic Large Cell Lymphoma. Advances in Hematology. 2010. 1–10. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kalman Filanovsky Breakdown of academic impact, for papers by Fatima Zahra Jelloul Breakdown of academic impact, for papers by Zoé Van de Wyngaert Breakdown of academic impact, for papers by Ryan J. Stubbins Breakdown of academic impact, for papers by Michel Maigre Breakdown of academic impact, for papers by Pedro Sánchez‐Godoy Breakdown of academic impact, for papers by Carmen Sanzo Breakdown of academic impact, for papers by Kaiyang Ding Breakdown of academic impact, for papers by H. Kreipe Breakdown of academic impact, for papers by Shlomzion Aumann
Rankless by CCL
2026